EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Paracrine action of bone morphogenetic protein 3 in pulmonary arterial hypertension

Aymen Halouani, Eric Mensah, Mariem Ben Rhouma, Zaujia Athumani, Michael G Katz, Seun Imani, Samar A Antar, Katherine Jankowski, Maryam Mansoori, Vicki Rosen, Kiyotake Ishikawa, Lahouaria Hadri und 1 weitere

European Respiratory Journal · 2026-11 · 68 (5) · 2502146

DOI: 10.1183/13993003.02146-2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Respiratory Journal, online erschienen am 30.07.2026. Verfasst von Aymen Halouani und 12 weiteren Autor:innen. Beteiligte Einrichtung: Fralin Biomedical Research Institute at Virginia Tech Carilion, Roanoke, VA, USA. Hauptthemen laut MEDLINE: Bone Morphogenetic Protein 3, Paracrine Communication, Hypertension, Pulmonary, Pulmonary Arterial Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite advances in therapy, pulmonary arterial hypertension (PAH) remains progressive with poor survival. Although dysregulation of bone morphogenetic protein (BMP) signalling is central to PAH, key modulators of this pathway remain incompletely defined.

Objectives

To identify the role of BMP3 in pulmonary vascular homeostasis and PAH.

Methods

BMP3 expression was assessed in experimental pulmonary hypertension and in pulmonary vascular cells and plasma from PAH patients. In vitro studies were performed in human pulmonary artery smooth muscle cells (hPASMCs) and endothelial cells (hPAECs). Global and smooth muscle cell-specific Bmp3 -deficient mice were generated. Recombinant BMP3 and adeno-associated viruses (AAVs) were used to overexpress BMP3 in animal models of PAH.

Results

BMP3 is predominantly expressed in PASMCs and is consistently downregulated in experimental and human PAH. Secreted BMP3 from PAH-PASMCs and circulating BMP3 levels in PAH patients were significantly reduced. Functionally, PASMC-derived BMP3 inhibited the migration and proliferation of PAH-diseased PAECs. In both global and smooth muscle cell-specific Bmp3 -deficient mice, induction of PAH led to significantly exacerbated disease in middle-aged mice. A recombinant BMP3 prevented and reversed PAH in mice. Furthermore, lung-targeted overexpression of BMP3, via AAV1-BMP3, reversed pulmonary vascular remodelling and ameliorated cardiac function in both mice and rats. Mechanistically, BMP3 restored the balance between BMP/SMAD1,5,8 and transforming growth factor (TGF)-β/SMAD2,3 signalling, and decreased the expression of cell cycle genes in PAECs.

Conclusions

BMP3 acts as a paracrine regulator of pulmonary vascular homeostasis and may contribute to the modulation of TGF-β/BMP signalling in PAH, highlighting its potential as a therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Morphogenetic Protein 3Paracrine CommunicationHypertension, PulmonaryPulmonary Arterial HypertensionAnimalsHumansMiceMyocytes, Smooth MuscleDisease Models, AnimalPulmonary ArterySignal TransductionMuscle, Smooth, VascularMaleEndothelial CellsCell ProliferationCell MovementRatsMice, Inbred C57BLMice, KnockoutFemaleDependovirus

Substanzen

Bone Morphogenetic Protein 3

Autor:innen und Institutionen

  • Fralin Biomedical Research Institute at Virginia Tech Carilion, Roanoke, VA, USA.
  • Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Department of Pharmacological Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Department of Developmental Biology, Harvard School of Dental Medicine, Boston, MA, USA.
  • Fralin Biomedical Research Institute at Virginia Tech Carilion, Roanoke, VA, USA sassiy@vt.edu.
  • Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, USA.

Förderung

  • NHLBI NIH HHS
  • NCATS NIH HHS
  • National Heart, Lung, and Blood Institute
  • American Heart Association
  • American Lung Association

Zitieren

APA

Halouani, A., Mensah, E., Ben Rhouma, M., Athumani, Z., Katz, M. G., Imani, S., Antar, S. A., Jankowski, K., Mansoori, M., Rosen, V., Ishikawa, K., Hadri, L., & Sassi, Y. (2026). Paracrine action of bone morphogenetic protein 3 in pulmonary arterial hypertension. European Respiratory Journal, 68(5), 2502146. https://doi.org/10.1183/13993003.02146-2025

Vancouver

Halouani A, Mensah E, Ben Rhouma M, Athumani Z, Katz MG, Imani S, et al. Paracrine action of bone morphogenetic protein 3 in pulmonary arterial hypertension. European Respiratory Journal. 2026;68(5):2502146. doi:10.1183/13993003.02146-2025

BibTeX
@article{Halouani2026,
  author = {Halouani, Aymen and Mensah, Eric and Ben Rhouma, Mariem and Athumani, Zaujia and Katz, Michael G and Imani, Seun and Antar, Samar A and Jankowski, Katherine and Mansoori, Maryam and Rosen, Vicki and Ishikawa, Kiyotake and Hadri, Lahouaria and Sassi, Yassine},
  title = {Paracrine action of bone morphogenetic protein 3 in pulmonary arterial hypertension},
  journal = {European Respiratory Journal},
  year = {2026},
  volume = {68},
  number = {5},
  pages = {2502146},
  doi = {10.1183/13993003.02146-2025}
}
Kostenlos starten →